Navigation Links
QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
Date:10/30/2007

s force and a global network of distributors in more than 40 countries.

Further information about QIAGEN can be found at http://www.qiagen.com.

(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/products/player/index.html, or The Windows Media Player, downloadable free from http://www.microsoft.com and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to webmaster@vdat.com.)


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
2. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
3. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
4. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
5. One-Third of Patients Discontinue Common Breast Cancer Therapy
6. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
7. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.comanno...atalogue. ,, HolterMonitoringSystems-AGlobalMa...164324/Holter-Monitoring-Systems---A-Global-Market...pr&utm_campaign=prnewswire ,, Cardiovas...ents.High-riskpatientsneedtobecontinuouslymonitore...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.comanno...atalogue. ,, AnesthesiaDisposables-AWorldMarke...276/Anesthesia-Disposables---A-World-Market-Review...utm_campaign=prnewswire ,, Globalgeneralane...eeofsaturation.Despitetheconsiderablerisewitnessed...
(Date:11/23/2009)..., BIRMINGHAM,Ala.andNOIDA,India,Nov.23/PRNewswire-...amaatBirmingham(UAB),andSouthernResearchInstitutet...gtheircollectiveinnovationandenablingtechnologiesi...iseases.ItisauniqueU.S.-Indiaarbitragedandleverage...rdabletherapiesforpatientsworldwide.AMemorandumofU...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 1OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 2OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 3Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 1Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 2WellTek MedX Group Completes Major Reorganization 6168 1WellTek MedX Group Completes Major Reorganization 6168 2
...e Francophone du Myelome (IFM),Trial Presented Dur...wire-FirstCall/ --,Millennium Pharmaceuticals, Inc...he comparative Phase III clinical trial evaluating...le myeloma (MM),patients. As induction therapy pri... based therapy produced a high complete remission,...
.../PRNewswire/ -- Portola,Pharmaceuticals, Inc. anno...linical data on its oral Factor Xa inhibitor and o... at the XXI Congress of,the International Society ...itzerland on July 6 through July 12, 2007. , The E...Company,s,lead compound PRT054021, is entitled "Ev...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 2Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 3
(Date:11/23/2009)...YHILL,N.J.,Nov.23/PRNewswire/--InasurveyofNewJerse...hiefFinancialOfficers,72percentdonotbelieveanewhea...tem. ,, Accordingtoresultsofthelatestsurveycond...untingfirm,theeconomytoppedthelistat85percentasthe...sestoits1500surveyssenttocompaniesfromallpartsofNe...
(Date:11/23/2009)...J. The Center for Science Writings at Stevens Ins...f God," a talk by Robert Wright, journalist and fo...09, 4:00-5:30 p.m. at the Babbio Center for Techno...pen to the public and the media., In his new boo...st Robert Wright, renowned for his popular works o...
(Date:11/23/2009)...Minn. -- Major medical errors self-reported by Ame...t and depression. Those findings appear today in t... Clinic-led study included collaborators from John..., In the confidential study, nearly 9 percent o...error in the three months prior to being surveyed....
(Date:11/23/2009)...N, Va. The Infectious Diseases Society of America...administration and the European Union to further t... 10 new antibiotics within the next 10 years, know...ganization (WHO) has identified antimicrobial resi...an health. , A new European Union report confirm...
(Date:11/23/2009)...in home-based settings get far more screen time t... , MONDAY, Nov. 23 (HealthDay News) --Young c...evision every day than previous reports have found... a new study finds. , Researchers from Seattle ...on surveyed day-care directors to find out how muc...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3
...iefu, vice minister of health in China has sought ... demand of organs by patients in their country//. ...ed for organ donations and the actual donations. ...onated by people after signing voluntary agreement...
...ng to a research conducted by Dr Michael Kisley, a...he US, older people have a more positive// outlook...e reported in the journal Psychological Science. ...ative aspects of life. The viewing was restricted ...
...nation of AZT, lamivudine, and nevirapine (AZT/3TC...e month after delivery resulted in significantly r...the HIV levels found in the breast milk of women w...s pilot study to examine the effect of using tripl...
...utes, perversions and public scandals – the stuff ...rs three centuries earlier,// according to new res...ing of erotic literature was already a social acti...tury Britain: "I tried to get a grip on just how m...
... has been declared free of neonatal tetanus by the... Kartar Devi said Saturday that a communication ha... welfare ministry, declaring that neonatal tetanus... a survey conducted by the central ministry on bir...
...s with arterial disease have relatively high rates...eart attack, stroke or //cardiovascular death) wit...f arterial locations afflicted, according to a stu...AD; narrowing of the arteries that supply the legs...
Other Medicine News:Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 2Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 3Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 4Health News:Sex – Three Hundred Years Ag 2Health News:Sex – Three Hundred Years Ag 3Health News:Atherothrombosis Associated With High Rates of Cardiovascular Events 2
...ion and tibial insert which provides a specially d...lexion to induce a smooth stable femoral roll-back...ral component comes in a PS open box design with p...ert in conjunction with the femur is designed to m...
Foundation® Knee CR System
...o provide the surgeon with surgical solutions for ...inically successful P.F.C. Total Knee System intro... innovation based on clinical proof.,P.F.C. SIGMA...izing femoro-tibial contact area, minimizing peak ...
BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
Medicine Products: